Navigation Links
Neptune Technologies decided not to re-price options
Date:9/12/2008

LAVAL, QC, Sept. 12 /PRNewswire-FirstCall/ - The Board of Directors of Neptune Technologies & Bioressources Inc. (NASDAQ.NEPT - TSX.V.NTB) decided not to re-price any options including the previously announced 850,000 options owned by officers and directors.

About Neptune Technologies

Neptune researches and develops proprietary bioactive ingredients and products for nutraceutical and pharmaceutical applications and is sponsoring clinical research to demonstrate the therapeutic benefits in various medical indications. The Company patents its intellectual property, protects its industrial secrets and innovations and continuously expands its intellectual property portfolio. Neptune has already obtained many regulatory approvals allowing commercialization of its products in various geographic markets and has filed for and is expecting additional approvals. Neptune continues to strongly support its strategic development plan to form partnerships with worldwide leaders in the nutraceutical industries. Neptune has signed agreements with Nestle and Yoplait, worldwide leading food manufacturers, and paved its entrance into the global functional food market.

Neither NASDAQ nor TSX venture exchange accepts responsibility for the

adequacy or accuracy of this press release.

Statements in this press release that are not statements of historical or current fact constitute "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and Canadian securities laws. Such forward-looking statements involve known and unknown risks, uncertainties, and other unknown factors that could cause the actual results of the Company to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements which explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms "
'/>"/>

SOURCE NEPTUNE TECHNOLOGIES & BIORESSOURCES INC.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Neptune Technologies successfully completes up to $8.5 million debt financing with Desjardins Group
2. Neptune Technologies Reports Record Fiscal 2008 Fourth Quarter and Year End Results
3. Neptune Technologies & Bioressources Inc. reports third quarter results and update on strategic milestones
4. The Omega-3 Industry Leader, Croda Health Care, selects Neptune Technologies Ingredients for New Essentially Brand
5. Neptune Technologies patent granted for novel phospholipids in multiple diseases and pharmaceutical applications
6. Neptune Technologies expands into medicinal markets in Asia Pacific
7. Neptune Technologies receives GRAS notification in the United States
8. Neptune Technologies & Bioressources Inc. obtains Complementary Medicine approval in Australia for NKO(R)
9. Neptune Technologies & Bioressources Inc. Secures Access to Nationwide Consumer Mass Market in the United States
10. Neptune strengthens scientific operations with the appointment of a new Scientific Advisory Board
11. Neptune Technologies & Bioressources Inc. Reports First Quarter Results and Business Update

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., COLUMBIA, Md., Dec. 2 /PRNewswire-FirstCall/ ... announced today that it intends to release the re...n December 16, 2009, at approximately 4:00 p.m. Ea....m. ET Martek will conduct a conference call to di...d parties may listen to the call live via webcast ...
(Date:12/2/2009)..., MANILA, Philippines, Dec. 2 Spec...growing green energy companies on the planet. Thro...e Green Planet,s President and Recycling Specialis...siness for over 25 years, stated that Spectrum Blu...tting the stage for spectacular earnings because o...
(Date:12/2/2009)... , NEW YORK, Dec. 2 Reportli...rt is available in its catalogue: ,, Neurostim...://www.reportlinker.com/p0164232/Neurostimulation-...ld neurostimulation market stands enthused by the ...t rise in age-related diseases such as, Parkinson,...
(Date:12/2/2009)... , NEW YORK, Dec. 2 Reportl...ort is available in its catalogue: ,, Carbondi..., http://www.reportlinker.com/p0164368/Carbondi...l ,, Incubators are the most critical equipme...h, and other applications for providing a controll...
Breaking Biology Technology:Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4
...RNewswire-FirstCall/ - Angiotech Pharmaceuticals,I... pharmaceutical and,medical device company, today ...ific Corporation "BSC" (NYSE: BSX ) has received ...xel-eluting coronary stent system in Canada.,BSC r...Directorate (TPD),the authority that regulates pha...
...ASgen, Inc. presented at the AACR,meeting in San D...,s lead,compound for ovarian cancer. FAS31 is an i...that is highly expressed in many human cancers. Nu... inhibition is cytotoxic to a,variety of human xen...icity,studies, FAS31 showed no observable toxicity...
... 18 ev3 Inc. (Nasdaq:,EVVV) will release its 2008... 2008, before regular market trading hours., The ...e same day at,7:30 a.m. CT (8:30 a.m. ET). ev3 man...sults and future outlook, followed by a question a...vailable to interested parties through a,live audi...
Other Biology Technology:Angiotech's Corporate Partner, Boston Scientific, Reports Canadian Approval for TAXUS(R) Liberte(R) Stent System 2Angiotech's Corporate Partner, Boston Scientific, Reports Canadian Approval for TAXUS(R) Liberte(R) Stent System 3Angiotech's Corporate Partner, Boston Scientific, Reports Canadian Approval for TAXUS(R) Liberte(R) Stent System 4FASgen, Inc. Presents Ovarian Cancer Efficacy and Toxicology Data to the American Association for Cancer Research 2
(Date:12/2/2009)... Children exposed to secondhand cigarette smoke ha...adulthood, even if they never smoked. , Results...gy, Biomarkers & Prevention , a journal of the Ame...a special tobacco focus in the December issue. ,...l be diagnosed with lung cancer; more than 159,000...
(Date:12/2/2009)...A Less acculturated Latino men have a more diffic...acculturated to U.S. culture, but acculturation ha...etails of these findings are published in Cancer ...of the American Association for Cancer Research. T..., "Acculturation affects smoking cessation diffe...
(Date:12/2/2009)... New study results strengthen the evidence that pe...me have an increased risk for developing colorecta...ors. , "This provides one more reason not to sm...author Michael J. Thun, M.D., M.S., vice president...at the American Cancer Society. "Colorectal cancer...
Breaking Biology News(10 mins):Secondhand smoke exposure in childhood increases lung cancer risk later in life 2Acculturation affects smoking cessation success among Latinos 2Cigarette smoking increases colorectal cancer risk 2FDLI Publishes New FDA Directory With Obama Appointees 52602 11 in 7 Low Income Preschoolers Is Obese 52597 11 in 7 Low Income Preschoolers Is Obese 52597 2Providence Service Corporation to Report Second Quarter 2009 Results on Monday August 10th After the Market Closes 52594 1Providence Service Corporation to Report Second Quarter 2009 Results on Monday August 10th After the Market Closes 52594 2Providence Service Corporation to Report Second Quarter 2009 Results on Monday August 10th After the Market Closes 52594 3
...ires in Indonesia responsible for some of the wor...t only to drought, but also to changes in land use...in Nature Geoscience led by Robert Field of the ...Indonesian Borneo changed from being highly fire-r..., marking the period when one of the world,s great...
... BIO-key International, Inc. (OTC Bulletin Board:...ication and wireless public safety solutions, anno...apital,s Homeland Security Investor Conference to ...ails regarding BIO-key,s participation at the conf...rial Capital,s Homeland Security Investor Conferen...
...ary 18 Precise Biometrics came in,first place in ...the GSMA,World Mobile Congress - the world,s large...ile aviation solution is based on Precise Match-on...rprint recognition and mobile phones. , SIMagi...ive solutions for,mobile communication and Java ca...
Other Biology News:Atmospheric scientists trace the human role in Indonesian forest fires 2BIO-key(R) Announces Conference Schedule 2Mobile Communication Market Opens up for Biometrics - Precise Biometrics Awarded 1st Prize at GSMA World Mobile Congress 2
HRP Monoclonal-Goat Diluent - 5X Concentrate from BioFX Laboratories, Inc.
Rabbit Anti-Mouse Junctophilin-4, C-Terminus Monoclonal Antibody, Unconjugated, Clone PADZMD.487 from Invitrogen
...153; PCR Cloning Kits are designed to speed up the...oducts, regardless of sequence or type of polymera...including those that are difficult to clone by oth...code for potentially detrimental proteins can be c...
Mounting Medium from BioVision
Biology Products: